CDC now admit officially problems with PAXLOVID; "COVID-19 rebound has been reported to occur between 2 and 8 days after initial recovery and is characterized by a recurrence of COVID-19 symptoms"
palexander.substack.com
Discover more from Alexander COVID News-Dr. Paul Elias Alexander's substack
COVID-19 and SARS-CoV-2: natural immunity; innate immunity; vaccines and immune pressure; no vaccines for children; early outpatient treatment; lockdowns; school closures and mask mandates and vaccine mandates and emergency powers and truck convoy
Over 38,000 subscribers
Continue reading
CDC now admit officially problems with PAXLOVID; "COVID-19 rebound has been reported to occur between 2 and 8 days after initial recovery and is characterized by a recurrence of COVID-19 symptoms"
SOURCE:
'“relapse of COVID-19 symptoms and SARS-CoV-2 viral load following nirmatrelvir/ritonavir (NM/R) in 10 non-immunocompromised patients aged 31 to 71-years-old.”
SOURCE:
CDC updated PAXLOVID advisory
"COVID-19 rebound has been reported to occur between 2 and 8 days after initial recovery and is characterized by a recurrence of COVID-19 symptoms"
CDC now admit officially problems with PAXLOVID; "COVID-19 rebound has been reported to occur between 2 and 8 days after initial recovery and is characterized by a recurrence of COVID-19 symptoms"
Is this because the vaccinated can not clear the virus and the non neutralizing aBs are binding and helping the spike protein. Thanks Geert
As intended?